C. Nelson

Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates

Anja van Brabant Smith, David P. Davis, Dwight Barnes, 2014, Nucleic acids research.

Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.

R. Scheller, S. Scales, Cary D. Austin, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection.

G. Frantz, A. Ebens, H. Koeppen, 2009, Cancer research.

Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo.

Jeffrey T. Lau, R. Rowntree, B. Vollmar, 2019, Bioconjugate chemistry.

Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification.

Yichin Liu, Ely Cosino, R. Vandlen, 2018, Bioconjugate chemistry.

Real-time immuno-polymerase chain reaction in a 384-well format: detection of vascular endothelial growth factor and epidermal growth factor-like domain 7.

Y. Meng, Jean-Michel Vernes, R. Vandlen, 2014, Analytical biochemistry.

Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.

A. Ebens, S. Prabhu, F. Jacobson, 2008, Bioconjugate chemistry.